Salivary IL-6 could predict recurrence after surgery in mouth cancer patients
Salivary levels of the proinflammatory cytokine interleukin-6 could be a useful predictor for locoregional recurrence in oral squamous cell carcinoma patients who are treated surgically, report researchers.
No comments:
Post a Comment